Brief: Fusion Antibodies Awarded New Affinity Engineering Project For European Pharma Client
BRIEF-Fusion Antibodies Awarded New Affinity Engineering Project For European Pharma Client Nov 6 (Reuters) - Fusion Antibodies PLC FAB.L:
FUSION ANTIBODIES - FURTHER CONTRACT WITH RETURNING CLIENT
FUSION ANTIBODIES - AWARDED NEW AFFINITY ENGINEERING PROJECT FOR EUROPEAN PHARMA CLIENT
FUSION ANTIBODIES - RAMP PROJECT EXPECTED TO GENERATE REVENUES IN EXCESS OF £45,000 IN CURRENT FINANCIAL YEAR
Source text: ID:nRSF0433Ca
Further company coverage: FAB.L
(Reporting by Kisha Bhatt)
((Reuters.Briefs@thomsonreuters.com))
Recent news on Fusion Antibodies
See all newsBrief: Fusion Antibodies Awarded New Affinity Engineering Project For European Pharma Client
Fusion Antibodies - Further contract with returning client
Brief: Fusion Antibodies Announces New TGE And Cryoem Project With US Pharma Client
Fusion Antibodies - Contract win
Fusion Antibodies - AGM statement H1 trading and research update